George, D. J., Moore, E., Blobe, G. C., DeVito, N., Hanks, B. A., Harrison, M. R., … Taxter, T. (2022). 923P Molecular classification of cancers of unknown primary expands and refines treatment options. In Annals of Oncology (Vol. 33, pp. S968–S969). Elsevier BV. https://doi.org/10.1016/j.annonc.2022.07.1048

George, D. J., E. Moore, G. C. Blobe, N. DeVito, B. A. Hanks, M. R. Harrison, C. J. Hoimes, et al. “923P Molecular classification of cancers of unknown primary expands and refines treatment options.” In Annals of Oncology, 33:S968–69. Elsevier BV, 2022. https://doi.org/10.1016/j.annonc.2022.07.1048.

George DJ, Moore E, Blobe GC, DeVito N, Hanks BA, Harrison MR, et al. 923P Molecular classification of cancers of unknown primary expands and refines treatment options. In: Annals of Oncology. Elsevier BV; 2022. p. S968–9.

George, D. J., et al. “923P Molecular classification of cancers of unknown primary expands and refines treatment options.” Annals of Oncology, vol. 33, Elsevier BV, 2022, pp. S968–69. Crossref, doi:10.1016/j.annonc.2022.07.1048.

George DJ, Moore E, Blobe GC, DeVito N, Hanks BA, Harrison MR, Hoimes CJ, Jia J, Morse M, Jayaprakasan P, MacKelfresh A, Mulder H, Beauchamp K, Michuda J, Stumpe MC, Perakslis E, Taxter T. 923P Molecular classification of cancers of unknown primary expands and refines treatment options. Annals of Oncology. Elsevier BV; 2022. p. S968–S969.